Agios to Host First Quarter 2026 Financial Results Conference Call

The biopharmaceutical company will report Q1 2026 earnings on April 29.

Apr. 6, 2026 at 11:38am

Got story updates? Submit your updates here. ›

Agios Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on rare diseases, announced it will host a conference call and live webcast on Wednesday, April 29, 2026, at 8:00 a.m. ET to report its first quarter 2026 financial results and business highlights.

Why it matters

As a commercial-stage biopharmaceutical company, Agios' quarterly financial performance and business updates are closely watched by investors and the broader healthcare industry to gauge the company's progress in developing and commercializing innovative rare disease treatments.

The details

The live webcast will be accessible on the Investors section of Agios' website under the 'Events & Presentations' tab. A replay of the webcast will be available on the company's website approximately two hours after the event.

  • Agios will host the conference call and webcast on Wednesday, April 29, 2026 at 8:00 a.m. ET.
  • The webcast replay will be available on the company's website approximately two hours after the event.

The players

Agios Pharmaceuticals, Inc.

A commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases.

Got photos? Submit your photos here. ›

The takeaway

Agios' upcoming financial results call will provide important insights into the company's progress in advancing its rare disease pipeline and commercializing its innovative treatments, which are critical to its long-term success.